Neutrophil Depletion Reduces Myocardial Apoptosis and Attenuates NFκB Activation/TNFα Release After Ischemia and Reperfusion

Journal of Surgical Research

Volumn 135, Issue 1, 2006, Pages 170-178

  Kin, Hajime ^a   Wang, Ning Ping ^a   Halkos, Michael E ^a   Kerendi, Faraz ^a   Guyton, Robert A ^a   Zhao, Zhi Qing ^a  

^a Carlyle Fraser Heart Center   (United States)

Author keywords

apoptosis; Bcl 2 family; Caspase 3; ischemia reperfusion; neutrophils; NF B; TNF

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CASPASE 3; DNA FRAGMENT; GRANULOCYTE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; BINDING AFFINITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LYMPHOCYTE DEPLETION; MALE; NEUTROPHIL; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RAT; RISK REDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOOD PRESSURE; CASPASE 3; CASPASES; CELL NUCLEUS; DNA FRAGMENTATION; HEART RATE; IMMUNE SERA; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MYOCARDIUM; NEUTROPHILS; NF-KAPPA B; OXIDANTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747044627     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.02.019     Document Type: Article

References (38)

1. Scarabelli T., Stephanou A., Rayment N., et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104 (2001) 253
2. Schmitt J.P., Schröder J., Schunkert H., Birnbaum D.E., and Aebert H. Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg 73 (2002) 1229
3. Qin F., Shite J., and Liang C.S. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF. Association with changes in MAPK pathways. Am J Physiol (Heart Circ Physiol) 285 (2003) H822
4. Nerheim P., Krishnan S.C., Olshansky B., and Shivkumar K. Apoptosis in the genesis of cardiac rhythm disorders. Cardiol Clin 19 (2001) 155
5. Zhao Z.Q., Morris C.D., Budde J.M., et al. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovas Res 59 (2003) 132
6. MacCarthy P.A., and Shah A.M. Oxidative stress and heart failure. Cor Art Dis 14 (2003) 109
7. Yamamoto H., Moriyama Y., Hisatomi K., Yotsumoto G., Taira A., and Sakata R. A leukocyte depleting filter reduces endothelial cell dysfunction and improves transplanted canine heart function. J Heart Lung Transplant 20 (2001) 670
8. Dhalla N.S., Elmoselhi A.B., Hata T., and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47 (2000) 446
9. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol (Heart Circ Physiol) 280 (2001) H2649
10. Budde J.M., Velez D.A., Zhao Z., et al. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion. Cardiovasc Res 47 (2000) 294
11. Nakamura M., Wang N.P., Zhao Z.Q., et al. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovas Res 45 (2000) 661
12. Zhao Z.Q., Velez D.A., Wang N.P., et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 6 (2001) 279
13. Dun Y., Zhi J.M., Sun H.Y., Zhao R.R., and Zhao Z.Q. Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol. Methods Find Exp Clin Pharmacol 24 (2002) 403
14. Brown M., McGuinness M., Wright T., et al. Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology. Differences between acute and chronic stimuli in vivo. Am J Physiol (Heart Circ Physiol) 289 (2005) H466
15. Abraham E., Luce J.M., Yaffe M.B., and Fink M.P. NF-κB activation. Crit Care Med 28 (2000) N100
16. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 274 (1998) R577
17. Zhao Z.Q., and Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 55 (2002) 438
18. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovas Res 43 (1999) 860
19. Sheridan B.C., McIntyre Jr. R.C., Meldrum D.R., et al. Antibody-mediated neutrophil depletion preserves pulmonary vasomotor function. J Surg Res 62 (1996) 74
20. Sener G., Tosun O., Sehirli A.O., et al. Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. Life Sci 72 (2003) 2707
21. Bohle R.M., Pich S., and Klein H.H. Modulation of the inflammatory response in experimental myocardial infarction. Eur Heart J 12 Suppl D (1991) 28
22. Romson J.L., Hook B.G., Kunkel S.L., Abrams G.D., Schork M.A., and Lucchesi B.R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67 (1983) 1016
23. Robaye B., Mosselmans R., Fiers W., Dumont J.E., and Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 138 (1991) 447
24. Chiang C.H., Wu C.P., Perng W.C., Yan H.C., and Yu C.P. Use of anti-(tumour necrosis factor-alpha) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischaemia/reperfusion injury. Clin Sci (Lond) 99 (2000) 215
25. Haunstetter A., and Izumo S. Apoptosis. Basic mechanisms and implications for cardiovascular disease. Circ Res 82 (1998) 1111
26. Onai Y., Suzuki J., Kakuta T., et al. Inhibition of IkB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovas Res 63 (2004) 51
27. Chandra J., Samali A., and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29 (2000) 323
28. Halestrap A.P., Kerr P.M., Javadov S., and Woodfield K.Y. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366 (1998) 79
29. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition. A common pathway to necrosis and apoptosis. Biochem Biophys Res Comm 304 (2003) 463
30. Esposti M.D., and Dive C. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Comm 304 (2003) 455
31. Kuwana T., and Newmeyer D.D. Bcl-2-family proteins and the role of mitochondria in apoptosis. Current Opinion Cell Biol 15 (2003) 691
32. Wang N., and Stemerman M.B. Ref-1 and transcriptional control of endothelial apoptosis. Circ Res 88 (2001) 1223
33. Kis A., Yellon D.M., and Baxter G.F. Role of nuclear factor-κB activation in acute ischaemia-reperfusion injury in myocardium. Br J Pharmacol 138 (2003) 894
34. Thourani V.H., Brar S.S., Kennedy T.P., et al. Nonanticoagulant heparin inhibits NF-κB activation and attenuates myocardial reperfusion injury. Am J Physiol 48 (2000) H2084
35. Cargnoni A., Ceconi C., Gaia G., Agnoletti G., and Ferrari R. Cellular thiols redox status. A switch for NF-κB activation during myocardial post-ischaemic reperfusion. J Mol Cell Cardiol 34 (2002) 997
36. Pye J., Ardeshirpour F., McCain A., et al. Proteasome inhibition ablates activation of NF-kB in myocardial reperfusion and reduces reperfusion injury. Am J Physiol (Heart Circ Physiol) 284 (2003) H919
37. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61 (2004) 481
38. Palatianos G.M., Balentine G., Papadakis E.G., et al. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg 77 (2004) 961